Elevated CD154 (CD40 ligand) synthesis in T-cells from allergic patients after nonspecific stimulation in vitro

U R Markert1, C Bär, J H Niess

  • 1Institut für Klinische Immunologie, Friedrich-Schiller-Universität, Jena, Germany.

Insights

T-cells from allergic patients show a higher capacity for CD154 synthesis compared to healthy individuals. This enhanced CD154 (CD40 ligand) production may contribute to elevated IgE levels in allergies.

Area of Science:

  • Immunology
  • Allergy Research
  • Cell Biology

Background:

  • The CD154 molecule (CD40 ligand) on T-cells interacts with CD40 on B-cells, crucial for immunoglobulin class switching.
  • Allergic diseases are often associated with elevated IgE production by B-cells.

Purpose of the Study:

  • To compare the intracellular CD154 expression in T-cells from allergic patients and healthy donors following non-specific stimulation.
  • To investigate the potential role of T-cell CD154 synthesis in the pathogenesis of allergic diseases.

Main Methods:

  • Blood samples from 104 allergic patients and 44 healthy donors were analyzed.
  • T-cells were isolated and stimulated with phorbol-12-myristate-13-acetate and ionomycin.
  • Intracellular CD154 expression was quantified using fluorescence-activated cell sorter (FACS) analysis.

Main Results:

  • Allergic patients exhibited a significantly higher increase in intracellular CD154+ T-cells (6.1%) and mean fluorescence intensity (28.1%) compared to healthy donors (1.4% and 4.6%, respectively).
  • These findings indicate an elevated capacity for CD154 synthesis in T-cells from allergic individuals.
  • The results suggest a potential link between enhanced T-cell CD154 production and increased IgE levels in allergic patients.

Conclusions:

  • T-cells from allergic patients demonstrate an enhanced capability for CD154 synthesis, independent of B-cells.
  • This heightened CD154 production may partially explain the enhanced IgE production observed in B-cells of allergic patients.
  • Further research is warranted to elucidate the precise mechanisms linking T-cell CD154 expression to allergic disease pathogenesis.